Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
Titel:
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
Auteur:
Buzzoni, R. Pusceddu, S. Bajetta, E. De Braud, F. Platania, M. Iannacone, C. Cantore, M. Mambrini, A. Bertolini, A. Alabiso, O. Ciarlo, A. Turco, C. Mazzaferro, V.